Log In
Print this Print this

TransCon hydrogel Insulin (ACP-002)

  Manage Alerts
Collapse Summary General Information
Company Ascendis Pharma A/S
DescriptionOnce-weekly basal insulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today